Mirvie Granted Breakthrough Device Designation For Test To Identify Risk Of Preeclampsia
Mirvie’s RNA platform can identify 75% of women who develop preeclampsia months before symptoms occur.
You may also be interested in...
Medtech Insight talked with Moshe Shoham about the innovative technologies behind surgical robotics companies Microbot Medical, XACT Robotics, Tamar Robotics and ForSight Robotics, which were all spun out of his laboratory in Israel.
Kurt Van den Bosch has been named CFO of J&J Medtech where he will report directly to Joe Wolk, J&J’s CFO.
Microbot Medical CEO Harel Gadot said a recent regulatory filing marks an important milestone in his company' efforts to bring the world’s first fully disposable endovascular robot to market.